Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus

Volker Vallon, Michael Rose, Maria Gerasimova, Joseph Satriano, Kenneth A. Platt, Hermann Koepsell, Robyn Cunard, Kumar Sharma, Scott C. Thomson, Timo Rieg

Research output: Contribution to journalArticle

164 Citations (Scopus)

Abstract

The Na-glucose cotransporter SGLT2 mediates high-capacity glucose uptake in the early proximal tubule and SGLT2 inhibitors are developed as new antidiabetic drugs. We used gene-targeted Sglt2 knockout (Sglt2-/-) mice to elucidate the contribution of SGLT2 to blood glucose control, glomerular hyperfiltration, kidney growth, and markers of renal growth and injury at 5 wk and 4.5 mo after induction of low-dose streptozotocin (STZ) diabetes. The absence of SGLT2 did not affect renal mRNA expression of glucose transporters SGLT1, NaGLT1, GLUT1, or GLUT2 in response to STZ. Application of STZ increased blood glucose levels to a lesser extent in Sglt2-/- vs. wild-type (WT) mice (~300 vs. 470 mg/dl) but increased glucosuria and food and fluid intake to similar levels in both genotypes. Lack of SGLT2 prevented STZ-induced glomerular hyperfiltration but not the increase in kidney weight. Knockout of SGLT2 attenuated the STZinduced renal accumulation of p62/sequestosome, an indicator of impaired autophagy, but did not attenuate the rise in renal expression of markers of kidney growth (p27 and proliferating cell nuclear antigen), oxidative stress (NADPH oxidases 2 and 4 and heme oxygenase-1), inflammation (interleukin-6 and monocyte chemoattractant protein-1), fibrosis (fibronectin and Sirius red-sensitive tubulointerstitial collagen accumulation), or injury (renal/urinary neutrophil gelatinase-associated lipocalin). SGLT2 deficiency did not induce ascending urinary tract infection in nondiabetic or diabetic mice. The results indicate that SGLT2 is a determinant of hyperglycemia and glomerular hyperfiltration in STZ-induced diabetes mellitus but is not critical for the induction of renal growth and markers of renal injury, inflammation, and fibrosis.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Renal Physiology
Volume304
Issue number2
DOIs
StatePublished - Jan 15 2013
Externally publishedYes

Fingerprint

Facilitative Glucose Transport Proteins
Hyperglycemia
Diabetes Mellitus
Kidney
Wounds and Injuries
Growth
Streptozocin
Experimental Diabetes Mellitus
Blood Glucose
Fibrosis
Inflammation
Glucose
Heme Oxygenase-1
Chemokine CCL2
NADPH Oxidase
Autophagy
Proliferating Cell Nuclear Antigen
Fibronectins
Hypoglycemic Agents
Knockout Mice

Keywords

  • Diabetes
  • Diabetic nephropathy
  • Fibrosis
  • Glomerular hyperfiltration
  • Inflammation
  • Proximal tubule
  • Renal growth

ASJC Scopus subject areas

  • Physiology
  • Urology

Cite this

Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus. / Vallon, Volker; Rose, Michael; Gerasimova, Maria; Satriano, Joseph; Platt, Kenneth A.; Koepsell, Hermann; Cunard, Robyn; Sharma, Kumar; Thomson, Scott C.; Rieg, Timo.

In: American Journal of Physiology - Renal Physiology, Vol. 304, No. 2, 15.01.2013.

Research output: Contribution to journalArticle

Vallon, Volker ; Rose, Michael ; Gerasimova, Maria ; Satriano, Joseph ; Platt, Kenneth A. ; Koepsell, Hermann ; Cunard, Robyn ; Sharma, Kumar ; Thomson, Scott C. ; Rieg, Timo. / Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus. In: American Journal of Physiology - Renal Physiology. 2013 ; Vol. 304, No. 2.
@article{e613d2775e4341429c1aa9a6a7c63728,
title = "Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus",
abstract = "The Na-glucose cotransporter SGLT2 mediates high-capacity glucose uptake in the early proximal tubule and SGLT2 inhibitors are developed as new antidiabetic drugs. We used gene-targeted Sglt2 knockout (Sglt2-/-) mice to elucidate the contribution of SGLT2 to blood glucose control, glomerular hyperfiltration, kidney growth, and markers of renal growth and injury at 5 wk and 4.5 mo after induction of low-dose streptozotocin (STZ) diabetes. The absence of SGLT2 did not affect renal mRNA expression of glucose transporters SGLT1, NaGLT1, GLUT1, or GLUT2 in response to STZ. Application of STZ increased blood glucose levels to a lesser extent in Sglt2-/- vs. wild-type (WT) mice (~300 vs. 470 mg/dl) but increased glucosuria and food and fluid intake to similar levels in both genotypes. Lack of SGLT2 prevented STZ-induced glomerular hyperfiltration but not the increase in kidney weight. Knockout of SGLT2 attenuated the STZinduced renal accumulation of p62/sequestosome, an indicator of impaired autophagy, but did not attenuate the rise in renal expression of markers of kidney growth (p27 and proliferating cell nuclear antigen), oxidative stress (NADPH oxidases 2 and 4 and heme oxygenase-1), inflammation (interleukin-6 and monocyte chemoattractant protein-1), fibrosis (fibronectin and Sirius red-sensitive tubulointerstitial collagen accumulation), or injury (renal/urinary neutrophil gelatinase-associated lipocalin). SGLT2 deficiency did not induce ascending urinary tract infection in nondiabetic or diabetic mice. The results indicate that SGLT2 is a determinant of hyperglycemia and glomerular hyperfiltration in STZ-induced diabetes mellitus but is not critical for the induction of renal growth and markers of renal injury, inflammation, and fibrosis.",
keywords = "Diabetes, Diabetic nephropathy, Fibrosis, Glomerular hyperfiltration, Inflammation, Proximal tubule, Renal growth",
author = "Volker Vallon and Michael Rose and Maria Gerasimova and Joseph Satriano and Platt, {Kenneth A.} and Hermann Koepsell and Robyn Cunard and Kumar Sharma and Thomson, {Scott C.} and Timo Rieg",
year = "2013",
month = "1",
day = "15",
doi = "10.1152/ajprenal.00409.2012",
language = "English (US)",
volume = "304",
journal = "American Journal of Physiology - Renal Fluid and Electrolyte Physiology",
issn = "0363-6127",
publisher = "American Physiological Society",
number = "2",

}

TY - JOUR

T1 - Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus

AU - Vallon, Volker

AU - Rose, Michael

AU - Gerasimova, Maria

AU - Satriano, Joseph

AU - Platt, Kenneth A.

AU - Koepsell, Hermann

AU - Cunard, Robyn

AU - Sharma, Kumar

AU - Thomson, Scott C.

AU - Rieg, Timo

PY - 2013/1/15

Y1 - 2013/1/15

N2 - The Na-glucose cotransporter SGLT2 mediates high-capacity glucose uptake in the early proximal tubule and SGLT2 inhibitors are developed as new antidiabetic drugs. We used gene-targeted Sglt2 knockout (Sglt2-/-) mice to elucidate the contribution of SGLT2 to blood glucose control, glomerular hyperfiltration, kidney growth, and markers of renal growth and injury at 5 wk and 4.5 mo after induction of low-dose streptozotocin (STZ) diabetes. The absence of SGLT2 did not affect renal mRNA expression of glucose transporters SGLT1, NaGLT1, GLUT1, or GLUT2 in response to STZ. Application of STZ increased blood glucose levels to a lesser extent in Sglt2-/- vs. wild-type (WT) mice (~300 vs. 470 mg/dl) but increased glucosuria and food and fluid intake to similar levels in both genotypes. Lack of SGLT2 prevented STZ-induced glomerular hyperfiltration but not the increase in kidney weight. Knockout of SGLT2 attenuated the STZinduced renal accumulation of p62/sequestosome, an indicator of impaired autophagy, but did not attenuate the rise in renal expression of markers of kidney growth (p27 and proliferating cell nuclear antigen), oxidative stress (NADPH oxidases 2 and 4 and heme oxygenase-1), inflammation (interleukin-6 and monocyte chemoattractant protein-1), fibrosis (fibronectin and Sirius red-sensitive tubulointerstitial collagen accumulation), or injury (renal/urinary neutrophil gelatinase-associated lipocalin). SGLT2 deficiency did not induce ascending urinary tract infection in nondiabetic or diabetic mice. The results indicate that SGLT2 is a determinant of hyperglycemia and glomerular hyperfiltration in STZ-induced diabetes mellitus but is not critical for the induction of renal growth and markers of renal injury, inflammation, and fibrosis.

AB - The Na-glucose cotransporter SGLT2 mediates high-capacity glucose uptake in the early proximal tubule and SGLT2 inhibitors are developed as new antidiabetic drugs. We used gene-targeted Sglt2 knockout (Sglt2-/-) mice to elucidate the contribution of SGLT2 to blood glucose control, glomerular hyperfiltration, kidney growth, and markers of renal growth and injury at 5 wk and 4.5 mo after induction of low-dose streptozotocin (STZ) diabetes. The absence of SGLT2 did not affect renal mRNA expression of glucose transporters SGLT1, NaGLT1, GLUT1, or GLUT2 in response to STZ. Application of STZ increased blood glucose levels to a lesser extent in Sglt2-/- vs. wild-type (WT) mice (~300 vs. 470 mg/dl) but increased glucosuria and food and fluid intake to similar levels in both genotypes. Lack of SGLT2 prevented STZ-induced glomerular hyperfiltration but not the increase in kidney weight. Knockout of SGLT2 attenuated the STZinduced renal accumulation of p62/sequestosome, an indicator of impaired autophagy, but did not attenuate the rise in renal expression of markers of kidney growth (p27 and proliferating cell nuclear antigen), oxidative stress (NADPH oxidases 2 and 4 and heme oxygenase-1), inflammation (interleukin-6 and monocyte chemoattractant protein-1), fibrosis (fibronectin and Sirius red-sensitive tubulointerstitial collagen accumulation), or injury (renal/urinary neutrophil gelatinase-associated lipocalin). SGLT2 deficiency did not induce ascending urinary tract infection in nondiabetic or diabetic mice. The results indicate that SGLT2 is a determinant of hyperglycemia and glomerular hyperfiltration in STZ-induced diabetes mellitus but is not critical for the induction of renal growth and markers of renal injury, inflammation, and fibrosis.

KW - Diabetes

KW - Diabetic nephropathy

KW - Fibrosis

KW - Glomerular hyperfiltration

KW - Inflammation

KW - Proximal tubule

KW - Renal growth

UR - http://www.scopus.com/inward/record.url?scp=84872400230&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872400230&partnerID=8YFLogxK

U2 - 10.1152/ajprenal.00409.2012

DO - 10.1152/ajprenal.00409.2012

M3 - Article

C2 - 23152292

AN - SCOPUS:84872400230

VL - 304

JO - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

JF - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

SN - 0363-6127

IS - 2

ER -